CE vs COLL
Celanese Corporation (CE) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CE currently screens at market cap $5.92B. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CE and COLL stock pages for the full models.
Not investment advice.